Pulmonology Medical News about Pulmonary Disease, Chronic Obstructive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
COPD: Journal of Chronic Obstructive Pulmonary Disease, 10/05/09

Anzueto A et al. – FSC 250/50 is more effective than SAL at reducing the rate of moderate/severe exacerbations. These data confirm the beneficial effect of FSC on the management of COPD exacerbations and support the use of FSC in patients with COPD.

<< Previous
Effect of tiotropium on outcomes in patients with moderate...

Next >>
Obstructive sleep apnea as a risk factor for coronary events or...

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09 Relevance Score: 90%

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/05/09 Relevance Score: 90%

Chronic Obstructive Pulmonary Disease
Internet Source, 10/30/09 Relevance Score: 89%

CAM and Respiratory Disease
Nutrition in Clinical Practice, 10/30/09 Relevance Score: 89%

The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease
Internet Source, 10/09/09 Relevance Score: 89%